+987.9%
MRNA vs NUE
+86.4%
+901.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NUE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -2.1% | +15.2% | +11.6% |
| 7D | +20.6% | -1.4% | +22.1% | +19.6% |
| 30D | +27.1% | +6.6% | +20.6% | +32.8% |
| 3M | +353.4% | -2.0% | +355.4% | +366.2% |
| 6M | +446.3% | +19.2% | +427.0% | +417.5% |
| YTD | +776.2% | +65.6% | +710.6% | +539.7% |
| 1Y | +987.9% | +87.8% | +900.1% | +552.3% |
| All | +987.9% | +86.4% | +901.5% | +552.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NUE.
Daily Out/Under-Performance
Portfolio return minus NUE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NUE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NUE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling